India's Natco Pharma gains as expansion plans support earnings outlook

ICRA

01/12/2025 09:35

** Drug maker Natco Pharma's NATP.NS stock up 2.5%; earlier rose as much as 5.22% to 923 rupees

** Rating agency ICRA reaffirms ICRAAA (Stable)/ ICRAA1+ credit ratings of NATP, citing notable market position, strong portfolio of complex generics, R&D capabilities

** Sees NATP's expansion in emerging markets such as Saudi Arabia, Algeria, Morocco, Egypt, Latin America as key positive

** NATP has also incorporated units in Brazil, Canada, Indonesia, Singapore, Philippines, UK and Columbia, to set up front-end presence

** With the expansion, NATP will be able to achieve higher profitability in the upcoming quarters, says ICRA, while flagging potential litigation risks

** NATP down 37% YTD vs 2.6% drop in pharma index .NIPHARM, exchange data shows

 (Reporting by Bharath Rajeswaran in Bengaluru)

 ((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))